Aquestive Therapeutics Inc (AQST) Options

Smart man 

Exactly

No brainer!

May breakout soon. Adding and building large position. I like their drugs.

Building a position here.

$AQST

Seeing how fast Neffy maker moved AQST will make the same move.

NEFFY is approved. Bad news for AQST very behind

Selloff coming

Not true

Nothing. No updates on Libervant after approval. Now Anaphylm won’t be available for 2 more years.

Keep dropping were not done buying!

Huge buy opp!

It’s heading back to $2. Stop the bleeding please! drug approved but not ready to sell wtf is that? Next earnings will be brutal.

added. Great science and beautiful chart.
Offerings became bullish.. dont you know?

Is a bargain

AQST under $5

Big turn around imminent

Yessir absolutely

In other words you’re confident about this one from the clinical stage drug discovery sector

Not for long

AQST under $5

AQST................................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783

AQST new 52 week hi

AQST...........................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783

I HATE YOU NOW..LOL

AQST new 52 week high

AQST.....................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783

Headed much higher!

AQST..EXIT...MASSIVE PLAY

AQST...BREAKING 4 BUCKS...BEAST

AQST...MONSTER

AQST...MONSTER

AQST monster bio by the master trend

AQST.......................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783

AQST new 52 week high

AQST...NEXT BIO WEEKLY BEAST

Just the beginning

AQST new 52 week high

Offering coming probably soon.

AQST new 52 week high

Initiating this one. Fantastic turnaround by company leadership. Look at the ER from last night and see for yourself.

Toxic slobs is more like it.

On going S-3 shelf placement!

AQST

Aquestive Therapeutics Announces EPIPHAST II Trial Data For AQST-109; Says 'AQST-109 median time to maximum concentration (Tmax) of 12 minutes was faster than EpiPen Tmax of 22.5 minutes'
7:05 am ET September 27, 2022 (Benzinga) Print
AQST-109 median time to maximum concentration (Tmax) of 12 minutes was faster than EpiPen® Tmax of 22.5 minutes
AQST-109 repeat dosing provided significantly higher drug plasma concentrations with a Tmax of 8 minutes after administration
Changes in systolic blood pressure and heart rate were similar after a single dose of AQST-109 when compared to a single dose of EpiPen
End-of-Phase 2 meeting with FDA scheduled for fourth quarter 2022 and remaining clinical studies will commence thereafter
Company hosts conference call at 8:00 am ET on September 27, 2022

https://www.stockscores.com/chart.asp?TickerSymbol=aqst%20&TimeRange=1825&Interval=m&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=AccDist&Indicator2=CMF&Indicator3=StochRSI&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen

me=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=AccDist&Indicator2=CMF&Indicator3=StochRSI&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen

nice

like this

strange POS

strange POS